Midwest Chest Consultants, PC

Saint Charles, Missouri 63301-2847

0 studies enrolling now · 10 studies all time

What they study most

Asthma, COPD, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Emphysema

Studies at this site

• A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD — Running, not enrolling
• A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma — Completed
• A Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD — Completed
• A Phase II Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Single Inhaled Doses of Ensifentrine-glycopyrrolate Fixed Dose Combination, Ensifentrine, and Glycopyrrolate in Subjects With Chronic Obstructive Pulmonary Disease — Completed
• Impairments That Affect Correct Inhaler Use in COPD — Running, not enrolling
• Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD — Completed
• A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD — Completed
• Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma — Completed
• To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD — Completed
• Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD — Completed